Atlas Trials

A Study to Determine the Safety, Tolerability, and Efficacy of SHR-1209 in Patients With Familial Hypercholesterolemia

Clinical trial NCT04455581 · UNKNOWN

Trial details

NCT number
NCT04455581
Sponsor
Jiangsu HengRui Medicine Co., Ltd.
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Familial Hypercholesterolemia
Start date
2020-09-01
Primary completion
2021-06-30
Enrollment
8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.